Teva offers to buy Mylan in cash-and-stock deal valued at approximately $40.1 billion
April 21, 2015 at 09:14 AM EDT
Teva has offered to buy Mylan in a cash-and-stock deal valued at about $40.1 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.